imatinib mesylate has been researched along with Leukemic Infiltration in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (66.67) | 29.6817 |
2010's | 3 (25.00) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
Authors | Studies |
---|---|
Arous, R; Benchabane, H; Boudiaf, H; Boukhelal, H; Chikhi, L; Ezziane, K; Hakem, S; Himrane, M; Rouis, NO | 1 |
Ottmann, OG; Pfeifer, H | 1 |
Hamada, Y; Ito, I; Ito, Y; Maruyama, S; Masuda, T; Matsuo, S; Mizuno, M; Ozaki, T; Sato, W; Tatematsu, M; Yasuda, Y; Yuzawa, Y | 1 |
Cho, JH; Hur, M; Kim, WS; Ko, YS; Lee, MH; Moon, HW; Yun, YM | 1 |
Ghosh, B; Goel, N; Pangtey, B; Raina, UK; Thakar, M | 1 |
Adams, R; Albritton, K; Coffin, C; Goldsby, R; Pulsipher, M; Wagner, L | 1 |
Bauer, H; Frickhofen, N; Hochhaus, A; Jung, B; Märker-Hermann, E; Reiter, A; Walz, C | 1 |
Ahmed, T; Liu, D; Madahar, CJ; Mathews, T; Seiter, K | 1 |
Czepulkowski, B; Jan-Mohamed, R; Kaczmarski, R; Pavlu, J | 1 |
Duch-Samper, A; Hurtado-Sarrió, M; Martínez-Dominguez, JA; Menezo-Rozalén, JL; Senent-Peris, ML; Taboada-Esteve, J | 1 |
Benson, RE; Farthing, PM; Loescher, AR; North, S; Payne, M; Rodd, HD | 1 |
Draznin, J; Parisi, E; Porter, D; Schuster, SJ; Sollecito, TP; Stoopler, E | 1 |
2 review(s) available for imatinib mesylate and Leukemic Infiltration
Article | Year |
---|---|
Therapy-related acute leukemia with mixed phenotype and t(9;22)(q32;q11.2): a case report and review of the literature.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Back; Benzamides; Bone Marrow; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 9; Cytarabine; Endometrial Neoplasms; Female; Gene Rearrangement; Genes, abl; Humans; Idarubicin; Imatinib Mesylate; Immunophenotyping; Induction Chemotherapy; Karyotyping; Leukemia, Myeloid, Acute; Leukemic Infiltration; Middle Aged; Neoplasms, Second Primary; Piperazines; Pyrimidines; Remission Induction; Soft Tissue Neoplasms; Submandibular Gland Neoplasms; Translocation, Genetic | 2012 |
Acute myelogenous leukemia: advances and limitations of treatment.
Topics: Adult; Aminoglycosides; Anthracyclines; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Benzamides; Case-Control Studies; Cytarabine; Fatal Outcome; Gemtuzumab; Gingiva; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Immunosuppressive Agents; Immunotoxins; Leukemia, Myeloid, Acute; Leukemic Infiltration; Male; Piperazines; Pyrimidines; Remission Induction; Sialic Acid Binding Ig-like Lectin 3 | 2002 |
10 other study(ies) available for imatinib mesylate and Leukemic Infiltration
Article | Year |
---|---|
Isolated blast crisis relapse in the central nervous system of a patient treating for a chronic myelogenous leukemia.
Topics: Adolescent; Algeria; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Central Nervous System; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemic Infiltration; Recurrence | 2020 |
Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Antibodies, Bispecific; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Central Nervous System; Child; Combined Modality Therapy; Dasatinib; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Leukemic Infiltration; Mutation; Neoplasm Proteins; Neoplasm, Residual; Philadelphia Chromosome; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyrimidines; Salvage Therapy; Secondary Prevention; Thiazoles; Transplantation Conditioning | 2009 |
Acute kidney injury presenting a feature of leukemic infiltration during therapy for chronic myelogenous leukemia.
Topics: Acute Kidney Injury; Aged, 80 and over; Benzamides; Diagnosis, Differential; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemic Infiltration; Male; Piperazines; Pyrimidines | 2010 |
Chronic myeloid leukemia presenting with bilateral central retinal vein occlusion and massive retinal infiltrates.
Topics: Adolescent; Allopurinol; Antineoplastic Agents; Benzamides; Bone Marrow; Drug Therapy, Combination; Humans; Hydroxyurea; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemic Infiltration; Male; Piperazines; Proto-Oncogene Proteins c-bcr; Pyrimidines; Retina; Retinal Neoplasms; Retinal Vein Occlusion; Vision Disorders; Visual Acuity | 2012 |
Unexpected pleural effusions in 3 pediatric patients treated with STI-571.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Marrow Transplantation; Camptothecin; Child; Combined Modality Therapy; Edema; Enzyme Inhibitors; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Irinotecan; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemic Infiltration; Lung Neoplasms; Male; Neoplasm Proteins; Neuroectodermal Tumors, Primitive; Piperazines; Pleural Effusion; Proto-Oncogene Proteins c-kit; Pyrimidines; Remission Induction; Sarcoma, Ewing; Testis; Topotecan | 2002 |
Complete molecular remission of chronic eosinophilic leukemia complicated by CNS disease after targeted therapy with imatinib.
Topics: Adult; Antineoplastic Agents; Arm; Azathioprine; Benzamides; Brain; Cerebellar Ataxia; Cerebellar Cortex; Enzyme Inhibitors; Headache; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Immunosuppressive Agents; Leukemic Infiltration; Magnetic Resonance Imaging; Male; Memory Disorders; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Paresis; Parietal Lobe; Piperazines; Polyarteritis Nodosa; Prednisone; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Remission Induction; Vertigo | 2004 |
Sweet's syndrome with CML cell infiltration of the skin in a patient with chronic-phase CML while taking Imatinib Mesylate.
Topics: Benzamides; Female; Humans; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Leukemia, Myeloid, Chronic-Phase; Leukemic Infiltration; Middle Aged; Piperazines; Pyrimidines; Remission Induction; Skin; Sweet Syndrome | 2004 |
Early blastic transformation with CNS infiltration in a patient with chronic myeloid leukaemia treated with imatinib.
Topics: Adult; Antineoplastic Agents; Benzamides; Blast Crisis; Blindness; Central Nervous System; Chromosomes, Human, Pair 10; Chromosomes, Human, Pair 19; Chromosomes, Human, Pair 6; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemic Infiltration; Male; Philadelphia Chromosome; Piperazines; Pyrimidines; Retina; Trisomy | 2005 |
Anterior chamber infiltration in a patient with Ph+ acute lymphoblastic leukemia in remission with imatinib.
Topics: Anterior Chamber; Antineoplastic Agents; Aqueous Humor; Benzamides; Eye Neoplasms; Female; Humans; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemic Infiltration; Middle Aged; Philadelphia Chromosome; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Remission Induction; Uveitis, Anterior | 2005 |
Leukaemic infiltration of the mandible in a young girl.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Marrow Transplantation; Child; Dexamethasone; Female; Humans; Imatinib Mesylate; Leukemic Infiltration; Mandible; Philadelphia Chromosome; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines | 2007 |